• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DRB1-DQB1单倍型对抗原肽的分子识别调节多发性硬化症易感性。

Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.

作者信息

Kumar Amit, Melis Paola, Genna Vito, Cocco Eleonora, Marrosu Maria Giovanna, Pieroni Enrico

机构信息

CRS4 Biomedicine, Science and Technology Park, Piscinamanna, Pula, Italy.

出版信息

Mol Biosyst. 2014 Aug;10(8):2043-54. doi: 10.1039/c4mb00203b.

DOI:10.1039/c4mb00203b
PMID:24853027
Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that has a notably high incidence in Sardinia. Our study focuses on two HLA class II haplotypes associated with the disease in Sardinia, the rare predisposing DRB115:01-DQB106:02 and the widespread protective DRB116:01-DQB105:02. This framework enabled the highlighting of HLA binding pocket specificity and peptide recognition mechanisms by employing molecular dynamics simulations of the whole DRB1-DQB1 haplotype interacting with MBP- and EBV-derived peptides. We analyzed peptide-protein interaction networks and temporal evolution of the original complexes and after key amino acid mutations. The mutation G86V of the protective DRB1 allele exerted its effect mainly in the presence of the EBV viral peptide, with local and long range outcomes. However, the V38A mutation of the protective DQB1 showed a long range effect only in the case of the MBP myelin peptide. Our findings also demonstrate a DRB1/DQB1 complementary molecular recognition of peptides. This mechanism could provide a robust synergistic action and a differential role of DRB1 and DQB1 in tissues and in the time-steps towards autoimmunity. In addition, we demonstrate that negatively charged residues in pockets 4 and 9 play a role in MS susceptibility. Our findings are supported by recent experiments using a closely related MS animal model. Overall, our analysis confirms the role of the DRB1-DQB1 haplotype in conferring disease predisposition and could provide a valuable aid in designing optimal therapeutic peptides for MS therapy.

摘要

多发性硬化症(MS)是一种中枢神经系统的自身免疫性疾病,在撒丁岛的发病率显著较高。我们的研究聚焦于撒丁岛与该疾病相关的两种HLA II类单倍型,即罕见的易感型DRB115:01 - DQB106:02和广泛存在的保护型DRB116:01 - DQB105:02。通过对整个DRB1 - DQB1单倍型与髓鞘碱性蛋白(MBP)和EB病毒衍生肽相互作用进行分子动力学模拟,该框架能够突出HLA结合口袋特异性和肽识别机制。我们分析了原始复合物以及关键氨基酸突变后的肽 - 蛋白质相互作用网络和时间演变。保护性DRB1等位基因的G86V突变主要在EB病毒肽存在时发挥作用,具有局部和远距离效应。然而,保护性DQB1的V38A突变仅在MBP髓鞘肽的情况下显示出远距离效应。我们的研究结果还证明了DRB1/DQB1对肽的互补分子识别。这种机制可以提供强大的协同作用以及DRB1和DQB1在组织中以及自身免疫发展的时间步长中的不同作用。此外,我们证明口袋4和9中的带负电荷残基在MS易感性中起作用。我们的研究结果得到了使用密切相关的MS动物模型的近期实验的支持。总体而言,我们的分析证实了DRB1 - DQB1单倍型在赋予疾病易感性方面的作用,并可为设计用于MS治疗的最佳治疗性肽提供有价值的帮助。

相似文献

1
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.DRB1-DQB1单倍型对抗原肽的分子识别调节多发性硬化症易感性。
Mol Biosyst. 2014 Aug;10(8):2043-54. doi: 10.1039/c4mb00203b.
2
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).DQB1*0602 而非 DRB1*1501 可使多发性硬化样疾病易感性增加,该疾病由蛋白脂质蛋白(PLP)诱导。
J Neuroinflammation. 2012 Feb 8;9:29. doi: 10.1186/1742-2094-9-29.
3
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.撒丁岛多发性硬化症人群中 HLA-DRB1-DQB1 单倍型的相互作用。
PLoS One. 2013 Apr 8;8(4):e59790. doi: 10.1371/journal.pone.0059790. Print 2013.
4
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.HLA-DRB1-DQB1 单体型与撒丁岛多发性硬化症的易感性和抗性有关。
PLoS One. 2012;7(4):e33972. doi: 10.1371/journal.pone.0033972. Epub 2012 Apr 11.
5
HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.在HLA - DR15(DRB1*1501;DQB1*0602)转基因小鼠的新型“人源化”多发性硬化症模型中,HLA - DQB1*0602决定疾病易感性。
J Immunol. 2009 Sep 1;183(5):3531-41. doi: 10.4049/jimmunol.0900784. Epub 2009 Jul 31.
6
The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.斯洛伐克人群中HLA - DRB1和HLA - DQB1等位基因与多发性硬化症遗传易感性的关联。
Neurol Res. 2015;37(12):1060-7. doi: 10.1080/01616412.2015.1115212. Epub 2016 Jan 8.
7
HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.HLA-II类分子与多发性硬化症的关联风险及保护作用——一项芬兰家族研究
J Neuroimmunol. 2002 Jan;122(1-2):140-5. doi: 10.1016/s0165-5728(01)00456-8.
8
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.HLA-DRB1*1501、-DQB1*0301、-DQB1*0302、-DQB1*0602和-DQB1*0603等位基因与多发性硬化症患者MRI上更严重的疾病结局相关。
Int Rev Neurobiol. 2007;79:521-35. doi: 10.1016/S0074-7742(07)79023-2.
9
Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.对多发性硬化症和发作性睡病家族中扩展的人类白细胞抗原(HLA)单倍型进行分析,证实了塔斯马尼亚多发性硬化症患者的I类区域存在易感性影响。
Immunogenetics. 2007 Mar;59(3):177-86. doi: 10.1007/s00251-006-0183-5. Epub 2007 Jan 26.
10
Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.摩洛哥人群中的遗传因素与多发性硬化症:HLA II类分子的作用
Pathol Biol (Paris). 2013 Dec;61(6):259-63. doi: 10.1016/j.patbio.2013.05.002. Epub 2013 Jul 9.

引用本文的文献

1
Template Entrance Channel as Possible Allosteric Inhibition and Resistance Site for Quinolines Tricyclic Derivatives in RNA Dependent RNA Polymerase of Bovine Viral Diarrhea Virus.作为牛病毒性腹泻病毒RNA依赖性RNA聚合酶中喹啉三环衍生物可能的变构抑制和抗性位点的模板入口通道
Pharmaceuticals (Basel). 2023 Mar 1;16(3):376. doi: 10.3390/ph16030376.
2
Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.多发性硬化症保护性等位基因 HLA-DRB1*01:01 对髓鞘和外源性抗原肽进行动力学区分。
Front Immunol. 2020 Jan 17;10:3088. doi: 10.3389/fimmu.2019.03088. eCollection 2019.
3
The impact of missense mutation in PIGA associated to paroxysmal nocturnal hemoglobinuria and multiple congenital anomalies-hypotonia-seizures syndrome 2: A computational study.
与阵发性夜间血红蛋白尿和多重先天性异常-低张力-癫痫综合征2相关的PIGA基因错义突变的影响:一项计算研究
Heliyon. 2019 Oct 23;5(10):e02709. doi: 10.1016/j.heliyon.2019.e02709. eCollection 2019 Oct.
4
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α-Antitrypsin Deficiency.外显子组测序揭示免疫基因在 α-抗胰蛋白酶缺乏个体中作为易感性修饰因子。
Sci Rep. 2019 Sep 11;9(1):13088. doi: 10.1038/s41598-019-49409-1.
5
Anti-Mycobacterial Antibodies in Paired Cerebrospinal Fluid and Serum Samples from Japanese Patients with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.来自日本多发性硬化症或视神经脊髓炎谱系障碍患者的配对脑脊液和血清样本中的抗分枝杆菌抗体
J Clin Med. 2018 Dec 7;7(12):522. doi: 10.3390/jcm7120522.
6
Influence of correlated antigen presentation on T-cell negative selection in the thymus.相关抗原呈递对胸腺中 T 细胞阴性选择的影响。
J R Soc Interface. 2018 Nov 7;15(148):20180311. doi: 10.1098/rsif.2018.0311.
7
p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer.p38丝裂原活化蛋白激酶信号通路及其在顺铂诱导的头颈癌化疗反应中与端粒重复结合因子2的相互作用
Oncogenesis. 2018 Jul 9;7(7):53. doi: 10.1038/s41389-018-0062-6.
8
Identification of new inhibitors against human Great wall kinase using in silico approaches.利用计算机模拟方法鉴定新型人 Great wall 激酶抑制剂。
Sci Rep. 2018 Mar 20;8(1):4894. doi: 10.1038/s41598-018-23246-0.
9
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.新型 2-苯并呋喃衍生物作为阿尔茨海默病的选择性丁酰胆碱酯酶抑制剂。
Sci Rep. 2018 Mar 13;8(1):4424. doi: 10.1038/s41598-018-22747-2.
10
Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor.人类自身免疫性 T 细胞受体交叉反应的动力学足迹。
Sci Rep. 2017 Feb 14;7:42496. doi: 10.1038/srep42496.